alastair gray

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	53021	19341
h-endeksi	110	63
i10-endeksi	379	258

4100

2050

1025

3075

1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025177 247 360 428 480 559 565 663 825 978 1035 1104 1340 1515 1786 2372 2551 2767 2997 3024 3098 3446 3573 3886 4014 3777 3466 576

Genel erişim

Tümünü görüntüle

221 makale

10 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Borislava MihaylovaUniversity of Oxford, Queen Mary University of Londondph.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Philip ClarkeProfessor of health economics, university of melbourneunimelb.edu.au üzerinde doğrulanmış e-posta adresine sahip
david p taggartProfessor of Cardiovascular Surgery Oxford Universityouh.nhs.uk üzerinde doğrulanmış e-posta adresine sahip
Oliver Rivero-AriasAssociate Professor, University of Oxfordnpeu.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Marcus FlatherUniversity of East Angliauea.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Andrew BriggsLondon School of Hygiene & Tropical Medicinelshtm.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Umberto BenedettoUniversity of Bristolbristol.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Helen A DakinHealth Economics Research Centre, University of Oxford, UKndph.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Colin BaigentProfessor of Epidemiology, Oxford Universityctsu.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Douglas G AltmanCentre for Statistics in Medicine, University of Oxfordcsm.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Mike RaynerProfessor of Population Health, University of Oxforddph.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Andrew FarmerProfessor of General Practice, University of Oxfordphc.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
a.mcguireProfessor of Health Economics, London School of Economicslse.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Andrew J CarrNuffield Professor of Orthopaedic Surgery, University of Oxfordndorms.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Ray FitzpatrickUniversity of Oxfordnuffield.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
David J BeardUniversity of Oxfordndorms.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Peter RothwellUniversity of Oxfordclneuro.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Peter ScarboroughUniversity of Oxfordphc.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Nigel ArdenUniversity of Oxfordndorms.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Kamlesh KhuntiProfessor of Primary Care Diabetes and Vascular Medicine, University of Leicesterle.ac.uk üzerinde doğrulanmış e-posta adresine sahip

Takip et

alastair gray

Emeritus Professor of Health Economics, University of Oxford

dph.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip

health economics


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials CT Trialists The Lancet 376 (9753), 1670-1681, 2010	4554*	2010
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ... Lancet (London, England) 380 (9841), 581-590, 2012	2440	2012
The economic burden of back pain in the UK N Maniadakis, A Gray Pain 84 (1), 95-103, 2000	2227	2000
Economic burden of cancer across the European Union: a population-based cost analysis R Luengo-Fernandez, J Leal, A Gray, R Sullivan The lancet oncology 14 (12), 1165-1174, 2013	1299	2013
Economic burden of cardiovascular diseases in the enlarged European Union J Leal, R Luengo-Fernández, A Gray, S Petersen, M Rayner European heart journal 27 (13), 1610-1619, 2006	1136	2006
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019	1030	2019
European cardiovascular disease statistics 2012 M Nichols, N Townsend, R Luengo-Fernandez, J Leal, A Gray, ...	996	2012
Applied methods of cost-effectiveness analysis in healthcare AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth OUP Oxford, 2010	885	2010
European cardiovascular disease statistics S Allender, P Scarborough, V Peto, M Rayner, J Leal, ... European Heart Network 3, 11-35, 2008	867	2008
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ... Diabetologia 47, 1747-1759, 2004	801	2004
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022	782*	2022
Knee replacement AJ Price, A Alvand, A Troelsen, JN Katz, G Hooper, A Gray, A Carr, ... The Lancet 392 (10158), 1672-1682, 2018	765	2018
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62) P Clarke, A Gray, R Holman Medical Decision Making 22 (4), 340-349, 2002	623	2002
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial JN Primrose, R Perera, A Gray, P Rose, A Fuller, A Corkhill, S George, ... Jama 311 (3), 263-270, 2014	547	2014
European cardiovascular disease statistics J Leal, R Luengo-Fernandez, A Gray British Heart Foundation, 2000	521	2000
Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial DJ Beard, JL Rees, JA Cook, I Rombach, C Cooper, N Merritt, BA Shirkey, ... The Lancet 391 (10118), 329-338, 2018	515	2018
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom … AJ Hayes, J Leal, AM Gray, RR Holman, PM Clarke Diabetologia 56, 1925-1933, 2013	508	2013
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) A Gray, M Raikou, A McGuire, P Fenn, R Stevens, C Cull, I Stratton, ... Bmj 320 (7246), 1373-1378, 2000	484	2000
Handling uncertainty when performing economic evaluation of healthcare interventions. AH Briggs, AM Gray Health technology assessment (Winchester, England) 3 (2), 1-134, 1999	474	1999
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open … PD Med Collaborative Group The Lancet 384 (9949), 1196-1205, 2014	470	2014

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar